Consistent results were observed inclinical cohorts, in which overexpression of AHNAK was associated with poorprognosis of NSCLC (19).Overexpression of ATRX(19) and HNRNPA3(59) was observed in NSCLC tumors and poor prognosis patients. Here, HNRNPA3 is linked to non-small cell lung carcinoma.